DDI Between BI Empagliflozin (10773) and Verapamil
Clinical trial NCT01276301 · COMPLETED
Trial details
- NCT number
- NCT01276301
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-02-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.